NantHealth
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NantHealth generated cash of -$32,264,000, which is less than the previous year. Cash used in financing activities reached the amount of $10,801,000 last year. Net change in cash is therefore -$27,843,000.
Cash Flow
| 2014 | -42.13M | -230.07M | 258.84M |
|---|---|---|---|
| 2015 | -75.75M | -93.51M | 171.68M |
| 2016 | -70.63M | -88.76M | 313.59M |
| 2017 | -81.14M | -12.27M | -5.33M |
| 2018 | -29.63M | -10.47M | -2.15M |
| 2019 | -8.76M | -4.29M | -32K |
| 2020 | -16.85M | 35.25M | -555K |
| 2021 | -27.68M | -5.63M | 40.57M |
| 2022 | -32.26M | -6.47M | 10.80M |
NH Cash Flow Statement (2014 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 31.40M | 24.16M | 6.37M | 19.44M | 62.01M | 160.35M | 5.98M | 3.69M | 17.01M |
Operating activities | |||||||||
Net income | -67.77M | -58.54M | -56.44M | -62.76M | -192.15M | -175.21M | -184.10M | -72.01M | -84.61M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 15.99M | 15.72M | 16.77M | 22.36M | 22.35M | 28.05M | 30.93M | 15.78M | 16.17M |
Stock-based compensation expense | 4.66M | 3.88M | 2.64M | 2.78M | 5.65M | 4.51M | 53.95M | 1.42M | 340K |
| Deferred income tax benefit | 4.66M | 3.88M | 2.64M | 2.78M | 5.65M | 4.51M | 53.95M | 1.42M | 340K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -204K | -2.66M | 4.78M | 3.31M | 406K | 4K | 8.11M | 3.58M | 468K |
Inventories | 0 | 9.62M | -18K | -302K | 343K | 196K | -570K | 989K | -2.30M |
Accounts payable | 7.21M | -1.91M | 1.43M | 1.36M | -1.66M | -1.85M | -5.64M | 1.73M | 1.63M |
Cash generated by operating activities | -32.26M | -27.68M | -16.85M | -8.76M | -29.63M | -81.14M | -70.63M | -75.75M | -42.13M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -360K | -31K | -15.21M | -251.72M |
Investments In Property Plant And Equipment | -6.47M | -5.08M | -5.67M | -4.59M | -10.54M | -13.63M | -15.78M | -13.24M | -11.63M |
Acquisitions Net | 0 | -556K | 40.92M | 300K | 68K | 1.72M | -74.36M | -201.36M | 7.21M |
Cash generated by investing activities | -6.47M | -5.63M | 35.25M | -4.29M | -10.47M | -12.27M | -88.76M | -93.51M | -230.07M |
Financing activities | |||||||||
Common Stock Issued | 24K | 0 | 0 | 0 | 0 | 0 | 83.56M | 200M | 260.52M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -98.81M | -1.84M | 0 | -93K | 0 | -23.32M | 0 | -1.97M |
Cash used in financing activities | 10.80M | 40.57M | -555K | -32K | -2.15M | -5.33M | 313.59M | 171.68M | 258.84M |
Net Change In Cash | -27.84M | 7.24M | 17.78M | -13.06M | -42.56M | -98.69M | 154.36M | 2.29M | -13.31M |
Cash at end of period | 3.55M | 31.40M | 24.16M | 6.37M | 19.44M | 61.66M | 160.35M | 5.98M | 3.69M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |